{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:47:38Z","timestamp":1794638858492,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer US","isbn-type":[{"value":"9781071609033","type":"print"},{"value":"9781071609040","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0904-0_13","type":"book-chapter","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T09:03:37Z","timestamp":1595581417000},"page":"145-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precise Drug Sequential Therapy Can Improve the Cardioversion Rate of Atrial Fibrillation with Valvular Disease after Radiofrequency Ablation"],"prefix":"10.1007","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"issue":"5","key":"13_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/joim.12478","volume":"279","author":"AJ Camm","year":"2016","unstructured":"Camm AJ, Savelieva I, Potpara T et al (2016) The changing circumstance of atrial fibrillation - progress towards precision medicine. J Intern Med 279(5):412\u2013427","journal-title":"J Intern Med"},{"issue":"14","key":"13_CR2","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309\u20131321","journal-title":"N Engl J Med"},{"issue":"15","key":"13_CR3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMe1501493","volume":"372","author":"HV Schaff","year":"2015","unstructured":"Schaff HV (2015) Surgical ablation of atrial fibrillation--when, why, and how? N Engl J Med 372(15):1465\u20131467","journal-title":"N Engl J Med"},{"issue":"15","key":"13_CR4","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1056\/NEJMoa1500528","volume":"372","author":"AM Gillinov","year":"2015","unstructured":"Gillinov AM, Gelijns AC, Parides MK et al (2015) Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med 372(15):1399\u20131409","journal-title":"N Engl J Med"},{"issue":"3","key":"13_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151248","volume":"11","author":"X Zhu","year":"2016","unstructured":"Zhu X, Li Q, Li Y et al (2016) Analysis of bipolar radiofrequency ablation in treatment of atrial fibrillation associated with rheumatic heart disease. PLoS One 11(3):e0151248","journal-title":"PLoS One"},{"issue":"5","key":"13_CR6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCRESAHA.117.311081","volume":"122","author":"J Heijman","year":"2018","unstructured":"Heijman J, Guichard JB, Dobrev D et al (2018) Translational challenges in atrial fibrillation. Circ Res 122(5):752\u2013773","journal-title":"Circ Res"},{"issue":"25","key":"13_CR7","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","volume":"358","author":"D Roy","year":"2008","unstructured":"Roy D, Talajic M, Nattel S et al (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358(25):2667\u20132677","journal-title":"N Engl J Med"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2482-14-32","volume":"14","author":"L Chen","year":"2014","unstructured":"Chen L, Xiao Y, Ma R et al (2014) Bipolar radiofrequency ablation is useful for treating atrial fibrillation combined with heart valve diseases. BMC Surg 14:32","journal-title":"BMC Surg"},{"issue":"3","key":"13_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00059-013-4032-7","volume":"40","author":"Q Yongjun","year":"2015","unstructured":"Yongjun Q, Huanzhang S, Wenxia Z et al (2015) From changes in local RAAS to structural remodeling of the left atrium: a beautiful cycle in atrial fibrillation. Herz 40(3):514\u2013520","journal-title":"Herz"},{"issue":"3","key":"13_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1470320312460897","volume":"14","author":"Y Qian","year":"2013","unstructured":"Qian Y, Liu Y, Tang H et al (2013) Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease. J Renin-Angiotensin-Aldosterone Syst 14(3):204\u2013211","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"11","key":"13_CR11","first-page":"674","volume":"39","author":"Y Qian","year":"2008","unstructured":"Qian Y, Shao H, Luo T et al (2008) Plasma angiotensin converting enzyme level and permanent atrial fibrillation with mitral valvular disease. Chin J Clin Thorac Cardiovasc Surg 39(11):674\u2013677","journal-title":"Chin J Clin Thorac Cardiovasc Surg"},{"issue":"3","key":"13_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/europace\/eup438","volume":"12","author":"Y Qian","year":"2010","unstructured":"Qian Y, Meng J, Tang H et al (2010) Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases. Europace 12(3):371\u2013377","journal-title":"Europace"},{"issue":"9994","key":"13_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0140-6736(15)60026-5","volume":"386","author":"L Macle","year":"2015","unstructured":"Macle L, Khairy P, Weerasooriya R et al (2015) Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet 386(9994):672\u2013679","journal-title":"Lancet"},{"issue":"19","key":"13_CR14","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma A, Jiang CY, Betts TR et al (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372(19):1812\u20131822","journal-title":"N Engl J Med"},{"issue":"2","key":"13_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/CIRCEP.114.001672","volume":"8","author":"D Schreiber","year":"2015","unstructured":"Schreiber D, Rostock T, Frohlich M et al (2015) Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success. Circ Arrhythm Electrophysiol 8(2):308\u2013317","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"13_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2012.02.009","volume":"165","author":"R Khatib","year":"2013","unstructured":"Khatib R, Joseph P, Briel M et al (2013) Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. Int J Cardiol 165(1):17\u201324","journal-title":"Int J Cardiol"},{"issue":"10","key":"13_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.cjca.2013.07.006","volume":"29","author":"AM Gillis","year":"2013","unstructured":"Gillis AM, Krahn AD, Skanes AC et al (2013) Management of atrial fibrillation in the year 2033: new concepts, tools, and applications leading to personalized medicine. Can J Cardiol 29(10):1141\u20131146","journal-title":"Can J Cardiol"},{"issue":"11","key":"13_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7326\/M13-1467","volume":"160","author":"SM Al-Khatib","year":"2014","unstructured":"Al-Khatib SM, Allen LaPointe NM, Chatterjee R et al (2014) Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med 160(11):760\u2013773","journal-title":"Ann Intern Med"},{"issue":"11","key":"13_CR19","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18(11):1609\u20131678","journal-title":"Europace"},{"issue":"1","key":"13_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/europace\/eut263","volume":"16","author":"P Kirchhof","year":"2014","unstructured":"Kirchhof P, Ammentorp B, Darius H et al (2014) Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events\u2014European Registry in Atrial Fibrillation (PREFER in AF). Europace 16(1):6\u201314","journal-title":"Europace"},{"issue":"11","key":"13_CR21","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/europace\/eut232","volume":"15","author":"P Kirchhof","year":"2013","unstructured":"Kirchhof P, Breithardt G, Aliot E et al (2013) Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork\/European Heart Rhythm Association consensus conference. Europace 15(11):1540\u20131556","journal-title":"Europace"},{"key":"13_CR22","doi-asserted-by":"crossref","unstructured":"Lafuente-Lafuente C, Valembois L, Bergmann JF et al (2015) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev (3):Cd005049","DOI":"10.1002\/14651858.CD005049.pub4"},{"issue":"15","key":"13_CR23","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/01.CIR.0000062689.04037.3F","volume":"107","author":"J Ausma","year":"2003","unstructured":"Ausma J, van der Velden HM, Lenders MH et al (2003) Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 107(15):2051\u20132058","journal-title":"Circulation"},{"issue":"Suppl 5","key":"13_CR24","doi-asserted-by":"publisher","first-page":"v121","DOI":"10.1093\/europace\/eus280","volume":"14","author":"M Shenasa","year":"2012","unstructured":"Shenasa M, Soleimanieh M, Shenasa F (2012) Individualized therapy in patients with atrial fibrillation: new look at atrial fibrillation. Europace 14(Suppl 5):v121\u2013v124","journal-title":"Europace"},{"issue":"4","key":"13_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1510\/icvts.2008.191403","volume":"8","author":"F Roshanali","year":"2009","unstructured":"Roshanali F, Mandegar MH, Yousefnia MA et al (2009) Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis. Interact Cardiovasc Thorac Surg 8(4):421\u2013425","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"13_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1536\/ihj.50.465","volume":"50","author":"T Komatsu","year":"2009","unstructured":"Komatsu T, Tachibana H, Sato Y et al (2009) Long-term efficacy of upstream therapy using angiotensin-converting enzyme inhibitors and statins in combination with antiarrhythmic agents for the treatment of paroxysmal atrial fibrillation. Int Heart J 50(4):465\u2013476","journal-title":"Int Heart J"},{"issue":"3","key":"13_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1177\/147323000803600319","volume":"36","author":"YJ Qian","year":"2008","unstructured":"Qian YJ, Xiao XJ, Yuan HS et al (2008) Combination pharmacological cardioversion of permanent atrial fibrillation in post-prosthetic mitral valve replacement outpatients: a novel approach for the treatment of atrial fibrillation. J Int Med Res 36(3):537\u2013543","journal-title":"J Int Med Res"}],"container-title":["Methods in Molecular Biology","Precision Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0904-0_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T20:05:49Z","timestamp":1595621149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0904-0_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071609033","9781071609040"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0904-0_13","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-0716-0904-0","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"25 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}